Several observational and controlled studies have found that oral squamous cell carcinoma and oral potentially malignant diseases (OPMDs) are associated with dyslipidemia (17), and controlled studies have found that cholesterol, LDL, and Apo B levels are significantly lower in oral cancers and patients (18). This evidence concerns the gene APOB and metabolic syndrome.